Assignee
- Institut National De La Sante Et De La Recherche Medicale (Inserm)
- Universite Paul Sabatier—Toulouse Iii
Inventors
- Elvire Gouze (6 patents)
{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Soluble fibroblast growth factor receptor 3 (FGR3) polypeptide for use in the prevention or treatment of skeletal growth retardation disorders", "item": "https://www.patentleaderboard.com/patent/10724014"}]}
Skip to contentUS Patent 10724014 · Granted Jul 28, 2020